Last quarter (Q4 2022), Merck KGaA's total revenue was €5.66B, an increase of 8.57% from the same quarter last year. In Q4, Merck KGaA's net income was €655.00M. See Merck KGaA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	€ 22.23B	-	€ 22.23B	€ 19.69B	€ 17.53B	€ 16.15B
Cost of Revenue	€ 8.53B	-	€ 8.53B	€ 7.35B	€ 6.83B	€ 6.21B
Gross Profit	€ 13.71B	-	€ 13.71B	€ 12.34B	€ 10.70B	€ 9.95B
Operating Expense	€ 8.96B	-	€ 8.95B	€ 8.14B	€ 7.89B	€ 7.64B
Operating Income	€ 4.75B	-	€ 4.75B	€ 4.20B	€ 2.81B	€ 2.30B
Net Non Operating Interest Income Expense	€ -165.00M	-	€ -164.00M	€ -226.00M	€ -348.00M	€ -410.00M
Other Income Expense	-	-	-	-	-	-
Pretax Income	€ 4.29B	-	€ 4.29B	€ 3.92B	€ 2.63B	€ 1.74B
Tax Provision	€ 948.00M	-	€ 948.00M	€ 859.00M	€ 637.00M	€ 440.00M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	€ 3.33B	-	€ 3.33B	€ 3.06B	€ 1.99B	€ 1.32B
Basic EPS	€ 6.13	-	€ 7.65	€ 7.03	€ 4.57	€ 3.04
Diluted EPS	€ 6.13	-	€ 7.65	€ 7.03	€ 4.57	€ 3.04
Basic Average Shares	€ 1.31B	-	€ 434.78M	€ 434.78M	€ 434.78M	€ 434.78M
Diluted Average Shares	€ 1.31B	-	€ 434.78M	€ 434.78M	€ 434.78M	€ 434.78M
Dividend Per Share	€ 1.85	-	€ 1.85	€ 1.40	€ 1.30	€ 1.25
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	€ 7.73	-	€ 10.05	€ 8.72	€ 6.70	€ 5.56
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	€ 17.48B	-	€ 17.48B	€ 15.49B	€ 14.72B	€ 13.85B
Net Income From Continuing And Discontinued Operation	€ 3.33B	-	€ 3.33B	€ 3.06B	€ 1.99B	€ 1.32B
Normalized Income	€ 3.48B	-	€ 3.48B	€ 3.06B	€ 1.82B	€ 1.35B
Interest Expense	€ 240.00M	-	€ 235.00M	€ 272.00M	€ 387.00M	€ 476.00M
EBIT	€ 4.53B	-	€ 4.52B	€ 4.20B	€ 3.02B	€ 2.21B
EBITDA	€ 6.56B	€ 5.68B	€ 6.55B	€ 5.96B	€ 4.96B	€ 4.16B

Currency in EUR

Merck KGaA Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing